Summary
The analysis of cell-free fetal DNA in the circulation of the pregnant woman plays the pivotal role in noninvasive prenatal research. Here, we describe an improved method for the quantification of male DNA, which is a valuable research tool for the quantification of fetal DNA. The quantification of fetal DNA serves two main purposes. First, the levels may indicate certain pregnancy-related disorders such as preeclampsia even before onset of the disease; thus, the quantification may serve as a marker for early detection. Second, extraction and enrichment strategies of the fetal DNA compartment are important factors in the development and implementation of clinical tests, such as detection of fetal sex, Rhesus D status, point mutations, and aneuploidies. In this context, the quantification of fetal DNA is an important tool for the evaluation of protocols.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lo, Y. M., Corbetta, N., Chamberlain, P. F., et al.(1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350, 485–487.
Zhong, X. Y., Laivuori, H., Livingston, J. C., et al. (2001) Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am. J. Obstet. Gynecol. 184, 414–419.
Hahn, S., Zhong, X. Y., Burk, M. R., Troeger, C., and Holzgreve, W. (2000) Multiplex and real-time quantitative PCR on fetal DNA in maternal plasma. A comparison with fetal cells isolated from maternal blood. Ann. N Y Acad. Sci. 906, 148–152.
Rijnders, R. J., Christiaens, G. C., Bossers, B., van der Smagt, J. J., van der Schoot, C. E., and de Haas, M. (2004) Clinical applications of cell-free fetal DNA from maternal plasma. Obstet. Gynecol. 103, 157–164.
Rijnders, R. J., Van Der Luijt, R. B., Peters, E. D., et al. (2003) Earliest gestational age for fetal sexing in cell-free maternal plasma. Prenat. Diagn. 23, 1042–1044.
Li, Y., Zimmermann, B., Rusterholz, C., Kang, A., Holzgreve, W., and Hahn, S. (2004) Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin. Chem. 50, 1002–1011.
Li, Y., Di Naro, E., Vitucci, A., Zimmermann, B., Holzgreve, W., and Hahn, S. (2005) Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. J. Am. Med. Assoc. 293, 843–849.
Chan, K. C., Zhang, J., Hui, A. B., et al. (2004) Size distributions of maternal and fetal DNA in maternal plasma. Clin. Chem. 50, 88–92.
Lo, Y. M., Leung, T. N., Tein, M. S., et al. (1999) Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin. Chem. 45, 184–188.
Zimmermann, B., Holzgreve, W., Zhong, X. Y., and Hahn, S. (2002) Inability to clonally expand fetal progenitors from maternal blood. Fetal Diagn. Ther. 17, 97–100.
Swinkels, D. W., de Kok, J. B., Hendriks, J. C., Wiegerinck, E., Zusterzeel, P. L., and Steegers, E. A. (2002) Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin. Chem. 48, 650–653.
Farina, A., Sekizawa, A., Iwasaki, M., Matsuoka, R., Ichizuka, K., and Okai, T. (2004) Total cell-free DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening. Prenat. Diagn. 24, 722–726.
Farina, A., Le Shane, E. S., Romero, R., et al. (2005) High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am. J. Obstet. Gynecol. 193, 421–425.
Zhong, X. Y., Burk, M. R., Troeger, C., Jackson, L. R., Holzgreve, W., and Hahn, S. (2000) Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat. Diagn. 20, 795–798.
Lo, Y. M., Lau, T. K., Zhang, J., et al. (1999) Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin. Chem. 45, 1747–1751.
Zimmermann, B., El-Sheikhah, A., Nicolaides, K., Holzgreve, W., and Hahn, S. (2005) Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin. Chem. 51, 1598–1604.
Zimmermann, B. G., Holzgreve, W., Avent, N., and Hahn, S. (2006) Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Ann. N Y Acad. Sci. 1075, 347–349.
Daniels, G., Finning, K., Martin, P., and Summers, J. O. (2006) Fetal blood group genotyping. present and future. Ann. N Y Acad. Sci. 1075, 88–95.
Poon, L. L., Leung, T. N., Lau, T. K., Chow, K. C., and Lo, Y. M. (2002) Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin. Chem. 48, 35–41.
Ellison, S., English, C., Burns, M., and Keer, J. (2006) Routes to improving the reliability of low level DNA analysis using real-time PCR. BMC. Biotechnology 6, 33.
Lo, K.-W., Lo, Y M. D., Leung, S.-F., et al. (1999) Analysis of cell-free Epstein-Barr virus-associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin. Chem. 45, 1292–1294.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Zimmermann, B.G., Maddocks, D.G., Avent, N.D. (2008). Quantification of Circulatory Fetal DNA in the Plasma of Pregnant Women. In: Hahn, S., Jackson, L.G. (eds) Prenatal Diagnosis. Methods in Molecular Biology™, vol 444. Humana Press. https://doi.org/10.1007/978-1-59745-066-9_17
Download citation
DOI: https://doi.org/10.1007/978-1-59745-066-9_17
Publisher Name: Humana Press
Print ISBN: 978-1-58829-803-4
Online ISBN: 978-1-59745-066-9
eBook Packages: Springer Protocols